For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of this treatment and the formulated version represents a true breakthrough . These innovative therapies stabilize the transthyretin protein, halting its destructive build-up and reducing the severity of the illness. Patients are n… Read More